nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—hypertension—type 2 diabetes mellitus	0.342	1	CtDrD
Nifedipine—CALM1—type 2 diabetes mellitus	0.104	0.43	CbGaD
Nifedipine—ABCC2—type 2 diabetes mellitus	0.0488	0.203	CbGaD
Nifedipine—CYP2E1—type 2 diabetes mellitus	0.0343	0.142	CbGaD
Nifedipine—CYP1A2—type 2 diabetes mellitus	0.0326	0.135	CbGaD
Nifedipine—CYP3A4—type 2 diabetes mellitus	0.0216	0.0896	CbGaD
Nifedipine—ABCC3—Glyburide—type 2 diabetes mellitus	0.0158	0.0668	CbGbCtD
Nifedipine—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0127	0.0534	CbGbCtD
Nifedipine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00936	0.0395	CbGbCtD
Nifedipine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00748	0.0316	CbGbCtD
Nifedipine—ABCC2—Glyburide—type 2 diabetes mellitus	0.00719	0.0303	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.00711	0.03	CbGbCtD
Nifedipine—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.00711	0.03	CbGbCtD
Nifedipine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00711	0.03	CbGbCtD
Nifedipine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00677	0.0285	CbGbCtD
Nifedipine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00653	0.0275	CbGbCtD
Nifedipine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00633	0.0267	CbGbCtD
Nifedipine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00624	0.0263	CbGbCtD
Nifedipine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00603	0.0254	CbGbCtD
Nifedipine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00597	0.0252	CbGbCtD
Nifedipine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00555	0.0234	CbGbCtD
Nifedipine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00533	0.0225	CbGbCtD
Nifedipine—CACNA1S—pes—type 2 diabetes mellitus	0.00503	0.187	CbGeAlD
Nifedipine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00492	0.0207	CbGbCtD
Nifedipine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00483	0.0204	CbGbCtD
Nifedipine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00472	0.0199	CbGbCtD
Nifedipine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00472	0.0199	CbGbCtD
Nifedipine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00458	0.0193	CbGbCtD
Nifedipine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00435	0.0184	CbGbCtD
Nifedipine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00431	0.0182	CbGbCtD
Nifedipine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00426	0.018	CbGbCtD
Nifedipine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00421	0.0177	CbGbCtD
Nifedipine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00398	0.0168	CbGbCtD
Nifedipine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00385	0.0162	CbGbCtD
Nifedipine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00381	0.0161	CbGbCtD
Nifedipine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0038	0.016	CbGbCtD
Nifedipine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0036	0.0152	CbGbCtD
Nifedipine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00358	0.0151	CbGbCtD
Nifedipine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00347	0.0146	CbGbCtD
Nifedipine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00343	0.0145	CbGbCtD
Nifedipine—CYP3A5—Losartan—type 2 diabetes mellitus	0.00329	0.0139	CbGbCtD
Nifedipine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00327	0.0138	CbGbCtD
Nifedipine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00317	0.0134	CbGbCtD
Nifedipine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00315	0.0133	CbGbCtD
Nifedipine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00314	0.0132	CbGbCtD
Nifedipine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00303	0.0128	CbGbCtD
Nifedipine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00274	0.0116	CbGbCtD
Nifedipine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00245	0.0103	CbGbCtD
Nifedipine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00242	0.0102	CbGbCtD
Nifedipine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00234	0.00989	CbGbCtD
Nifedipine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00221	0.00932	CbGbCtD
Nifedipine—ABCB1—Losartan—type 2 diabetes mellitus	0.00214	0.00905	CbGbCtD
Nifedipine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00208	0.00877	CbGbCtD
Nifedipine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00199	0.00841	CbGbCtD
Nifedipine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00199	0.00841	CbGbCtD
Nifedipine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00189	0.00795	CbGbCtD
Nifedipine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0014	0.00593	CbGbCtD
Nifedipine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00128	0.00542	CbGbCtD
Nifedipine—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00117	0.0435	CbGeAlD
Nifedipine—KCNA1—nerve—type 2 diabetes mellitus	0.00109	0.0407	CbGeAlD
Nifedipine—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.000785	0.0292	CbGeAlD
Nifedipine—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.000569	0.0212	CbGeAlD
Nifedipine—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.000567	0.0211	CbGeAlD
Nifedipine—CACNA1S—cardiovascular system—type 2 diabetes mellitus	0.000487	0.0181	CbGeAlD
Nifedipine—KCNA1—retina—type 2 diabetes mellitus	0.000453	0.0169	CbGeAlD
Nifedipine—CALM2—artery—type 2 diabetes mellitus	0.000447	0.0167	CbGeAlD
Nifedipine—CALM1—artery—type 2 diabetes mellitus	0.000445	0.0166	CbGeAlD
Nifedipine—CALM2—nerve—type 2 diabetes mellitus	0.000444	0.0165	CbGeAlD
Nifedipine—CALM1—nerve—type 2 diabetes mellitus	0.000442	0.0164	CbGeAlD
Nifedipine—CACNB2—islet of Langerhans—type 2 diabetes mellitus	0.000405	0.0151	CbGeAlD
Nifedipine—CALM2—endothelium—type 2 diabetes mellitus	0.000378	0.0141	CbGeAlD
Nifedipine—CALM1—endothelium—type 2 diabetes mellitus	0.000376	0.014	CbGeAlD
Nifedipine—CACNA1D—islet of Langerhans—type 2 diabetes mellitus	0.000354	0.0132	CbGeAlD
Nifedipine—CACNB2—retina—type 2 diabetes mellitus	0.000346	0.0129	CbGeAlD
Nifedipine—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000313	0.0116	CbGeAlD
Nifedipine—CACNA1H—cardiovascular system—type 2 diabetes mellitus	0.00031	0.0115	CbGeAlD
Nifedipine—CACNB2—cardiovascular system—type 2 diabetes mellitus	0.000293	0.0109	CbGeAlD
Nifedipine—CACNB2—cortex of kidney—type 2 diabetes mellitus	0.000279	0.0104	CbGeAlD
Nifedipine—CACNA2D1—cardiovascular system—type 2 diabetes mellitus	0.000275	0.0102	CbGeAlD
Nifedipine—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.000274	0.0102	CbGeAlD
Nifedipine—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000268	0.00997	CbGeAlD
Nifedipine—CACNA1D—cardiovascular system—type 2 diabetes mellitus	0.000256	0.00953	CbGeAlD
Nifedipine—CACNA1D—pancreas—type 2 diabetes mellitus	0.000249	0.00926	CbGeAlD
Nifedipine—CACNA2D1—adipose tissue—type 2 diabetes mellitus	0.000243	0.00903	CbGeAlD
Nifedipine—CACNA1C—cardiovascular system—type 2 diabetes mellitus	0.000236	0.0088	CbGeAlD
Nifedipine—CALM3—retina—type 2 diabetes mellitus	0.000234	0.00871	CbGeAlD
Nifedipine—CALM3—nephron tubule—type 2 diabetes mellitus	0.00022	0.0082	CbGeAlD
Nifedipine—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.000215	0.008	CbGeAlD
Nifedipine—Felodipine—CALM1—type 2 diabetes mellitus	0.000214	0.134	CrCbGaD
Nifedipine—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.000214	0.00796	CbGeAlD
Nifedipine—ABCC3—kidney—type 2 diabetes mellitus	0.00021	0.00783	CbGeAlD
Nifedipine—CACNA1C—adipose tissue—type 2 diabetes mellitus	0.000208	0.00776	CbGeAlD
Nifedipine—CYP3A7—liver—type 2 diabetes mellitus	0.000204	0.00761	CbGeAlD
Nifedipine—Nicardipine—CALM1—type 2 diabetes mellitus	0.000204	0.128	CrCbGaD
Nifedipine—CYP2A6—adipose tissue—type 2 diabetes mellitus	0.000202	0.00753	CbGeAlD
Nifedipine—CALM3—pancreas—type 2 diabetes mellitus	0.000192	0.00716	CbGeAlD
Nifedipine—CACNA1H—liver—type 2 diabetes mellitus	0.000192	0.00714	CbGeAlD
Nifedipine—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000191	0.00712	CbGeAlD
Nifedipine—ABCC3—adipose tissue—type 2 diabetes mellitus	0.00019	0.00706	CbGeAlD
Nifedipine—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000189	0.00702	CbGeAlD
Nifedipine—CALM2—retina—type 2 diabetes mellitus	0.000184	0.00684	CbGeAlD
Nifedipine—CALM1—retina—type 2 diabetes mellitus	0.000183	0.00681	CbGeAlD
Nifedipine—CACNB2—liver—type 2 diabetes mellitus	0.000181	0.00674	CbGeAlD
Nifedipine—CALM3—adipose tissue—type 2 diabetes mellitus	0.000175	0.0065	CbGeAlD
Nifedipine—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000174	0.00647	CbGeAlD
Nifedipine—CALM2—nephron tubule—type 2 diabetes mellitus	0.000173	0.00644	CbGeAlD
Nifedipine—CALM1—nephron tubule—type 2 diabetes mellitus	0.000172	0.00641	CbGeAlD
Nifedipine—CACNA2D1—liver—type 2 diabetes mellitus	0.00017	0.00633	CbGeAlD
Nifedipine—ABCC2—kidney—type 2 diabetes mellitus	0.000168	0.00626	CbGeAlD
Nifedipine—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000164	0.00609	CbGeAlD
Nifedipine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000161	0.00599	CbGeAlD
Nifedipine—CACNA1D—liver—type 2 diabetes mellitus	0.000158	0.00589	CbGeAlD
Nifedipine—CALM2—cardiovascular system—type 2 diabetes mellitus	0.000155	0.00579	CbGeAlD
Nifedipine—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000155	0.00576	CbGeAlD
Nifedipine—CALM2—kidney—type 2 diabetes mellitus	0.000152	0.00566	CbGeAlD
Nifedipine—CALM1—kidney—type 2 diabetes mellitus	0.000151	0.00564	CbGeAlD
Nifedipine—CALM2—pancreas—type 2 diabetes mellitus	0.000151	0.00562	CbGeAlD
Nifedipine—CALM1—pancreas—type 2 diabetes mellitus	0.00015	0.0056	CbGeAlD
Nifedipine—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000148	0.00551	CbGeAlD
Nifedipine—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000147	0.00549	CbGeAlD
Nifedipine—CYP2A6—liver—type 2 diabetes mellitus	0.000142	0.00528	CbGeAlD
Nifedipine—CALM2—adipose tissue—type 2 diabetes mellitus	0.000137	0.0051	CbGeAlD
Nifedipine—CALM1—adipose tissue—type 2 diabetes mellitus	0.000136	0.00508	CbGeAlD
Nifedipine—ABCC3—liver—type 2 diabetes mellitus	0.000133	0.00495	CbGeAlD
Nifedipine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000129	0.00482	CbGeAlD
Nifedipine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000129	0.00479	CbGeAlD
Nifedipine—CYP2C8—kidney—type 2 diabetes mellitus	0.000126	0.00469	CbGeAlD
Nifedipine—CALM3—liver—type 2 diabetes mellitus	0.000122	0.00456	CbGeAlD
Nifedipine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000121	0.0045	CbGeAlD
Nifedipine—CYP1A1—kidney—type 2 diabetes mellitus	0.000116	0.00433	CbGeAlD
Nifedipine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000116	0.0043	CbGeAlD
Nifedipine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000114	0.00426	CbGeAlD
Nifedipine—CYP3A5—kidney—type 2 diabetes mellitus	0.000114	0.00424	CbGeAlD
Nifedipine—CYP2B6—kidney—type 2 diabetes mellitus	0.000113	0.00421	CbGeAlD
Nifedipine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000113	0.00421	CbGeAlD
Nifedipine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000111	0.00412	CbGeAlD
Nifedipine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000108	0.00404	CbGeAlD
Nifedipine—ABCC2—liver—type 2 diabetes mellitus	0.000106	0.00395	CbGeAlD
Nifedipine—CYP2E1—kidney—type 2 diabetes mellitus	0.000106	0.00395	CbGeAlD
Nifedipine—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000105	0.0039	CbGeAlD
Nifedipine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000103	0.00385	CbGeAlD
Nifedipine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000103	0.00382	CbGeAlD
Nifedipine—Clevidipine—CYP2E1—type 2 diabetes mellitus	9.93e-05	0.0623	CrCbGaD
Nifedipine—CALM2—liver—type 2 diabetes mellitus	9.61e-05	0.00358	CbGeAlD
Nifedipine—CALM1—liver—type 2 diabetes mellitus	9.57e-05	0.00356	CbGeAlD
Nifedipine—Clevidipine—CYP1A2—type 2 diabetes mellitus	9.45e-05	0.0592	CrCbGaD
Nifedipine—Nisoldipine—CYP1A2—type 2 diabetes mellitus	9.06e-05	0.0568	CrCbGaD
Nifedipine—Nilvadipine—CYP2E1—type 2 diabetes mellitus	8.91e-05	0.0558	CrCbGaD
Nifedipine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	8.54e-05	0.00318	CbGeAlD
Nifedipine—CYP3A4—kidney—type 2 diabetes mellitus	8.54e-05	0.00318	CbGeAlD
Nifedipine—Nilvadipine—CYP1A2—type 2 diabetes mellitus	8.47e-05	0.0531	CrCbGaD
Nifedipine—CYP2D6—kidney—type 2 diabetes mellitus	8.4e-05	0.00313	CbGeAlD
Nifedipine—CYP2C8—liver—type 2 diabetes mellitus	7.97e-05	0.00297	CbGeAlD
Nifedipine—Lercanidipine—CYP3A4—type 2 diabetes mellitus	7.86e-05	0.0492	CrCbGaD
Nifedipine—CYP1A2—liver—type 2 diabetes mellitus	7.46e-05	0.00278	CbGeAlD
Nifedipine—CYP1A1—liver—type 2 diabetes mellitus	7.35e-05	0.00274	CbGeAlD
Nifedipine—ABCB1—retina—type 2 diabetes mellitus	7.3e-05	0.00272	CbGeAlD
Nifedipine—Amlodipine—CYP1A2—type 2 diabetes mellitus	7.3e-05	0.0457	CrCbGaD
Nifedipine—CYP3A5—liver—type 2 diabetes mellitus	7.19e-05	0.00268	CbGeAlD
Nifedipine—CYP2B6—liver—type 2 diabetes mellitus	7.15e-05	0.00266	CbGeAlD
Nifedipine—Isradipine—CYP3A4—type 2 diabetes mellitus	7.1e-05	0.0445	CrCbGaD
Nifedipine—CYP2C9—liver—type 2 diabetes mellitus	7.08e-05	0.00263	CbGeAlD
Nifedipine—ABCB1—nephron tubule—type 2 diabetes mellitus	6.88e-05	0.00256	CbGeAlD
Nifedipine—Nicardipine—CYP2E1—type 2 diabetes mellitus	6.75e-05	0.0423	CrCbGaD
Nifedipine—CYP2E1—liver—type 2 diabetes mellitus	6.71e-05	0.0025	CbGeAlD
Nifedipine—Clevidipine—CYP3A4—type 2 diabetes mellitus	6.25e-05	0.0392	CrCbGaD
Nifedipine—ABCB1—cardiovascular system—type 2 diabetes mellitus	6.18e-05	0.0023	CbGeAlD
Nifedipine—ABCB1—kidney—type 2 diabetes mellitus	6.04e-05	0.00225	CbGeAlD
Nifedipine—ABCB1—pancreas—type 2 diabetes mellitus	6e-05	0.00224	CbGeAlD
Nifedipine—Nisoldipine—CYP3A4—type 2 diabetes mellitus	6e-05	0.0376	CrCbGaD
Nifedipine—ABCB1—cortex of kidney—type 2 diabetes mellitus	5.89e-05	0.00219	CbGeAlD
Nifedipine—Nimodipine—CYP3A4—type 2 diabetes mellitus	5.79e-05	0.0363	CrCbGaD
Nifedipine—Nitrendipine—CYP3A4—type 2 diabetes mellitus	5.61e-05	0.0352	CrCbGaD
Nifedipine—Nilvadipine—CYP3A4—type 2 diabetes mellitus	5.61e-05	0.0352	CrCbGaD
Nifedipine—ABCB1—adipose tissue—type 2 diabetes mellitus	5.45e-05	0.00203	CbGeAlD
Nifedipine—CYP3A4—liver—type 2 diabetes mellitus	5.4e-05	0.00201	CbGeAlD
Nifedipine—CYP2D6—liver—type 2 diabetes mellitus	5.31e-05	0.00198	CbGeAlD
Nifedipine—Amlodipine—CYP3A4—type 2 diabetes mellitus	4.83e-05	0.0303	CrCbGaD
Nifedipine—Felodipine—CYP3A4—type 2 diabetes mellitus	4.46e-05	0.028	CrCbGaD
Nifedipine—Nicardipine—CYP3A4—type 2 diabetes mellitus	4.25e-05	0.0266	CrCbGaD
Nifedipine—ABCB1—liver—type 2 diabetes mellitus	3.82e-05	0.00142	CbGeAlD
Nifedipine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	3.06e-05	0.000336	CcSEcCtD
Nifedipine—Nervous system disorder—Metformin—type 2 diabetes mellitus	3.06e-05	0.000336	CcSEcCtD
Nifedipine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	3.06e-05	0.000336	CcSEcCtD
Nifedipine—Dyspnoea—Valsartan—type 2 diabetes mellitus	3.06e-05	0.000336	CcSEcCtD
Nifedipine—Vertigo—Losartan—type 2 diabetes mellitus	3.05e-05	0.000335	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	3.05e-05	0.000335	CcSEcCtD
Nifedipine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	3.05e-05	0.000335	CcSEcCtD
Nifedipine—Somnolence—Valsartan—type 2 diabetes mellitus	3.05e-05	0.000335	CcSEcCtD
Nifedipine—Syncope—Losartan—type 2 diabetes mellitus	3.05e-05	0.000335	CcSEcCtD
Nifedipine—Paraesthesia—Orlistat—type 2 diabetes mellitus	3.04e-05	0.000334	CcSEcCtD
Nifedipine—Leukopenia—Losartan—type 2 diabetes mellitus	3.04e-05	0.000334	CcSEcCtD
Nifedipine—Discomfort—Irbesartan—type 2 diabetes mellitus	3.04e-05	0.000333	CcSEcCtD
Nifedipine—Skin disorder—Metformin—type 2 diabetes mellitus	3.03e-05	0.000333	CcSEcCtD
Nifedipine—Immune system disorder—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000332	CcSEcCtD
Nifedipine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	3.02e-05	0.000331	CcSEcCtD
Nifedipine—Dyspepsia—Valsartan—type 2 diabetes mellitus	3.02e-05	0.000331	CcSEcCtD
Nifedipine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000331	CcSEcCtD
Nifedipine—Dizziness—Bromocriptine—type 2 diabetes mellitus	3.01e-05	0.00033	CcSEcCtD
Nifedipine—Dry mouth—Irbesartan—type 2 diabetes mellitus	3.01e-05	0.00033	CcSEcCtD
Nifedipine—Palpitations—Losartan—type 2 diabetes mellitus	3e-05	0.00033	CcSEcCtD
Nifedipine—Nausea—Glimepiride—type 2 diabetes mellitus	2.99e-05	0.000329	CcSEcCtD
Nifedipine—Arrhythmia—Ramipril—type 2 diabetes mellitus	2.99e-05	0.000328	CcSEcCtD
Nifedipine—Loss of consciousness—Losartan—type 2 diabetes mellitus	2.99e-05	0.000328	CcSEcCtD
Nifedipine—Nausea—Sitagliptin—type 2 diabetes mellitus	2.98e-05	0.000328	CcSEcCtD
Nifedipine—Dyspepsia—Orlistat—type 2 diabetes mellitus	2.98e-05	0.000327	CcSEcCtD
Nifedipine—Asthenia—Glyburide—type 2 diabetes mellitus	2.98e-05	0.000327	CcSEcCtD
Nifedipine—Decreased appetite—Valsartan—type 2 diabetes mellitus	2.98e-05	0.000327	CcSEcCtD
Nifedipine—Anorexia—Metformin—type 2 diabetes mellitus	2.98e-05	0.000327	CcSEcCtD
Nifedipine—Cough—Losartan—type 2 diabetes mellitus	2.97e-05	0.000326	CcSEcCtD
Nifedipine—Urticaria—Gliclazide—type 2 diabetes mellitus	2.97e-05	0.000326	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	2.96e-05	0.000325	CcSEcCtD
Nifedipine—Alopecia—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000325	CcSEcCtD
Nifedipine—Fatigue—Valsartan—type 2 diabetes mellitus	2.96e-05	0.000325	CcSEcCtD
Nifedipine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	2.95e-05	0.000324	CcSEcCtD
Nifedipine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	2.95e-05	0.000324	CcSEcCtD
Nifedipine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	2.95e-05	0.000324	CcSEcCtD
Nifedipine—Oedema—Irbesartan—type 2 diabetes mellitus	2.95e-05	0.000324	CcSEcCtD
Nifedipine—Decreased appetite—Orlistat—type 2 diabetes mellitus	2.95e-05	0.000323	CcSEcCtD
Nifedipine—Pruritus—Glyburide—type 2 diabetes mellitus	2.94e-05	0.000323	CcSEcCtD
Nifedipine—Mental disorder—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000322	CcSEcCtD
Nifedipine—Constipation—Valsartan—type 2 diabetes mellitus	2.93e-05	0.000322	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	2.93e-05	0.000321	CcSEcCtD
Nifedipine—Fatigue—Orlistat—type 2 diabetes mellitus	2.92e-05	0.000321	CcSEcCtD
Nifedipine—Hypotension—Metformin—type 2 diabetes mellitus	2.92e-05	0.00032	CcSEcCtD
Nifedipine—Malnutrition—Ramipril—type 2 diabetes mellitus	2.91e-05	0.00032	CcSEcCtD
Nifedipine—Erythema—Ramipril—type 2 diabetes mellitus	2.91e-05	0.00032	CcSEcCtD
Nifedipine—Shock—Irbesartan—type 2 diabetes mellitus	2.9e-05	0.000318	CcSEcCtD
Nifedipine—Pain—Orlistat—type 2 diabetes mellitus	2.9e-05	0.000318	CcSEcCtD
Nifedipine—Chest pain—Losartan—type 2 diabetes mellitus	2.89e-05	0.000318	CcSEcCtD
Nifedipine—Arthralgia—Losartan—type 2 diabetes mellitus	2.89e-05	0.000318	CcSEcCtD
Nifedipine—Myalgia—Losartan—type 2 diabetes mellitus	2.89e-05	0.000318	CcSEcCtD
Nifedipine—Vomiting—Bromocriptine—type 2 diabetes mellitus	2.89e-05	0.000317	CcSEcCtD
Nifedipine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000317	CcSEcCtD
Nifedipine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000317	CcSEcCtD
Nifedipine—Anxiety—Losartan—type 2 diabetes mellitus	2.88e-05	0.000317	CcSEcCtD
Nifedipine—Tachycardia—Irbesartan—type 2 diabetes mellitus	2.88e-05	0.000316	CcSEcCtD
Nifedipine—Rash—Bromocriptine—type 2 diabetes mellitus	2.87e-05	0.000315	CcSEcCtD
Nifedipine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	2.86e-05	0.000314	CcSEcCtD
Nifedipine—Skin disorder—Irbesartan—type 2 diabetes mellitus	2.86e-05	0.000314	CcSEcCtD
Nifedipine—Tension—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000314	CcSEcCtD
Nifedipine—Discomfort—Losartan—type 2 diabetes mellitus	2.86e-05	0.000314	CcSEcCtD
Nifedipine—Dysgeusia—Ramipril—type 2 diabetes mellitus	2.85e-05	0.000313	CcSEcCtD
Nifedipine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	2.85e-05	0.000313	CcSEcCtD
Nifedipine—Headache—Bromocriptine—type 2 diabetes mellitus	2.85e-05	0.000313	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	2.85e-05	0.000312	CcSEcCtD
Nifedipine—Diarrhoea—Glyburide—type 2 diabetes mellitus	2.84e-05	0.000312	CcSEcCtD
Nifedipine—Nervousness—Ramipril—type 2 diabetes mellitus	2.83e-05	0.000311	CcSEcCtD
Nifedipine—Dry mouth—Losartan—type 2 diabetes mellitus	2.83e-05	0.000311	CcSEcCtD
Nifedipine—Anorexia—Irbesartan—type 2 diabetes mellitus	2.81e-05	0.000308	CcSEcCtD
Nifedipine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	2.8e-05	0.000308	CcSEcCtD
Nifedipine—Paraesthesia—Metformin—type 2 diabetes mellitus	2.8e-05	0.000308	CcSEcCtD
Nifedipine—Muscle spasms—Ramipril—type 2 diabetes mellitus	2.8e-05	0.000308	CcSEcCtD
Nifedipine—Confusional state—Losartan—type 2 diabetes mellitus	2.8e-05	0.000307	CcSEcCtD
Nifedipine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	2.79e-05	0.000307	CcSEcCtD
Nifedipine—Dyspnoea—Metformin—type 2 diabetes mellitus	2.78e-05	0.000306	CcSEcCtD
Nifedipine—Somnolence—Metformin—type 2 diabetes mellitus	2.78e-05	0.000305	CcSEcCtD
Nifedipine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	2.77e-05	0.000304	CcSEcCtD
Nifedipine—Oedema—Losartan—type 2 diabetes mellitus	2.77e-05	0.000304	CcSEcCtD
Nifedipine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	2.77e-05	0.000304	CcSEcCtD
Nifedipine—Hypotension—Irbesartan—type 2 diabetes mellitus	2.75e-05	0.000302	CcSEcCtD
Nifedipine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	2.75e-05	0.000302	CcSEcCtD
Nifedipine—Dyspepsia—Metformin—type 2 diabetes mellitus	2.75e-05	0.000302	CcSEcCtD
Nifedipine—Tremor—Ramipril—type 2 diabetes mellitus	2.73e-05	0.0003	CcSEcCtD
Nifedipine—Shock—Losartan—type 2 diabetes mellitus	2.73e-05	0.0003	CcSEcCtD
Nifedipine—Urticaria—Valsartan—type 2 diabetes mellitus	2.72e-05	0.000299	CcSEcCtD
Nifedipine—Nervous system disorder—Losartan—type 2 diabetes mellitus	2.72e-05	0.000299	CcSEcCtD
Nifedipine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	2.72e-05	0.000298	CcSEcCtD
Nifedipine—Decreased appetite—Metformin—type 2 diabetes mellitus	2.71e-05	0.000298	CcSEcCtD
Nifedipine—Abdominal pain—Valsartan—type 2 diabetes mellitus	2.71e-05	0.000298	CcSEcCtD
Nifedipine—Tachycardia—Losartan—type 2 diabetes mellitus	2.71e-05	0.000297	CcSEcCtD
Nifedipine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	2.7e-05	0.000297	CcSEcCtD
Nifedipine—Nausea—Bromocriptine—type 2 diabetes mellitus	2.7e-05	0.000297	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	2.7e-05	0.000296	CcSEcCtD
Nifedipine—Fatigue—Metformin—type 2 diabetes mellitus	2.69e-05	0.000296	CcSEcCtD
Nifedipine—Urticaria—Orlistat—type 2 diabetes mellitus	2.69e-05	0.000296	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	2.69e-05	0.000295	CcSEcCtD
Nifedipine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	2.68e-05	0.000294	CcSEcCtD
Nifedipine—Abdominal pain—Orlistat—type 2 diabetes mellitus	2.68e-05	0.000294	CcSEcCtD
Nifedipine—Body temperature increased—Orlistat—type 2 diabetes mellitus	2.68e-05	0.000294	CcSEcCtD
Nifedipine—Asthenia—Gliclazide—type 2 diabetes mellitus	2.68e-05	0.000294	CcSEcCtD
Nifedipine—Agitation—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000294	CcSEcCtD
Nifedipine—Constipation—Metformin—type 2 diabetes mellitus	2.67e-05	0.000293	CcSEcCtD
Nifedipine—Angioedema—Ramipril—type 2 diabetes mellitus	2.66e-05	0.000292	CcSEcCtD
Nifedipine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	2.65e-05	0.000291	CcSEcCtD
Nifedipine—Anorexia—Losartan—type 2 diabetes mellitus	2.64e-05	0.00029	CcSEcCtD
Nifedipine—Vomiting—Glyburide—type 2 diabetes mellitus	2.64e-05	0.00029	CcSEcCtD
Nifedipine—Pruritus—Gliclazide—type 2 diabetes mellitus	2.64e-05	0.00029	CcSEcCtD
Nifedipine—Malaise—Ramipril—type 2 diabetes mellitus	2.63e-05	0.000288	CcSEcCtD
Nifedipine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	2.63e-05	0.000288	CcSEcCtD
Nifedipine—Rash—Glyburide—type 2 diabetes mellitus	2.62e-05	0.000288	CcSEcCtD
Nifedipine—Somnolence—Irbesartan—type 2 diabetes mellitus	2.62e-05	0.000288	CcSEcCtD
Nifedipine—Dermatitis—Glyburide—type 2 diabetes mellitus	2.62e-05	0.000287	CcSEcCtD
Nifedipine—Vertigo—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000287	CcSEcCtD
Nifedipine—Syncope—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000287	CcSEcCtD
Nifedipine—Leukopenia—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000286	CcSEcCtD
Nifedipine—Headache—Glyburide—type 2 diabetes mellitus	2.6e-05	0.000286	CcSEcCtD
Nifedipine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	2.59e-05	0.000285	CcSEcCtD
Nifedipine—Hypotension—Losartan—type 2 diabetes mellitus	2.59e-05	0.000285	CcSEcCtD
Nifedipine—Palpitations—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000283	CcSEcCtD
Nifedipine—Feeling abnormal—Metformin—type 2 diabetes mellitus	2.57e-05	0.000283	CcSEcCtD
Nifedipine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	2.56e-05	0.000281	CcSEcCtD
Nifedipine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	2.56e-05	0.000281	CcSEcCtD
Nifedipine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	2.55e-05	0.00028	CcSEcCtD
Nifedipine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	2.55e-05	0.00028	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	2.54e-05	0.000279	CcSEcCtD
Nifedipine—Cough—Ramipril—type 2 diabetes mellitus	2.54e-05	0.000279	CcSEcCtD
Nifedipine—Fatigue—Irbesartan—type 2 diabetes mellitus	2.54e-05	0.000279	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	2.53e-05	0.000277	CcSEcCtD
Nifedipine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	2.53e-05	0.000277	CcSEcCtD
Nifedipine—Pain—Irbesartan—type 2 diabetes mellitus	2.52e-05	0.000277	CcSEcCtD
Nifedipine—Constipation—Irbesartan—type 2 diabetes mellitus	2.52e-05	0.000277	CcSEcCtD
Nifedipine—Insomnia—Losartan—type 2 diabetes mellitus	2.51e-05	0.000275	CcSEcCtD
Nifedipine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	2.5e-05	0.000274	CcSEcCtD
Nifedipine—Paraesthesia—Losartan—type 2 diabetes mellitus	2.49e-05	0.000273	CcSEcCtD
Nifedipine—Urticaria—Metformin—type 2 diabetes mellitus	2.48e-05	0.000272	CcSEcCtD
Nifedipine—Arthralgia—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000272	CcSEcCtD
Nifedipine—Chest pain—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000272	CcSEcCtD
Nifedipine—Myalgia—Ramipril—type 2 diabetes mellitus	2.48e-05	0.000272	CcSEcCtD
Nifedipine—Dyspnoea—Losartan—type 2 diabetes mellitus	2.47e-05	0.000271	CcSEcCtD
Nifedipine—Anxiety—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000271	CcSEcCtD
Nifedipine—Nausea—Glyburide—type 2 diabetes mellitus	2.47e-05	0.000271	CcSEcCtD
Nifedipine—Abdominal pain—Metformin—type 2 diabetes mellitus	2.47e-05	0.000271	CcSEcCtD
Nifedipine—Dizziness—Gliclazide—type 2 diabetes mellitus	2.47e-05	0.000271	CcSEcCtD
Nifedipine—Somnolence—Losartan—type 2 diabetes mellitus	2.47e-05	0.000271	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	2.46e-05	0.00027	CcSEcCtD
Nifedipine—Asthenia—Valsartan—type 2 diabetes mellitus	2.46e-05	0.00027	CcSEcCtD
Nifedipine—Discomfort—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000269	CcSEcCtD
Nifedipine—Dyspepsia—Losartan—type 2 diabetes mellitus	2.44e-05	0.000268	CcSEcCtD
Nifedipine—Asthenia—Orlistat—type 2 diabetes mellitus	2.43e-05	0.000267	CcSEcCtD
Nifedipine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	2.43e-05	0.000267	CcSEcCtD
Nifedipine—Pruritus—Valsartan—type 2 diabetes mellitus	2.43e-05	0.000266	CcSEcCtD
Nifedipine—Dry mouth—Ramipril—type 2 diabetes mellitus	2.43e-05	0.000266	CcSEcCtD
Nifedipine—Decreased appetite—Losartan—type 2 diabetes mellitus	2.41e-05	0.000265	CcSEcCtD
Nifedipine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	2.41e-05	0.000265	CcSEcCtD
Nifedipine—Confusional state—Ramipril—type 2 diabetes mellitus	2.4e-05	0.000263	CcSEcCtD
Nifedipine—Pruritus—Orlistat—type 2 diabetes mellitus	2.4e-05	0.000263	CcSEcCtD
Nifedipine—Fatigue—Losartan—type 2 diabetes mellitus	2.39e-05	0.000263	CcSEcCtD
Nifedipine—Oedema—Ramipril—type 2 diabetes mellitus	2.38e-05	0.000261	CcSEcCtD
Nifedipine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	2.38e-05	0.000261	CcSEcCtD
Nifedipine—Vomiting—Gliclazide—type 2 diabetes mellitus	2.37e-05	0.000261	CcSEcCtD
Nifedipine—Constipation—Losartan—type 2 diabetes mellitus	2.37e-05	0.00026	CcSEcCtD
Nifedipine—Pain—Losartan—type 2 diabetes mellitus	2.37e-05	0.00026	CcSEcCtD
Nifedipine—Rash—Gliclazide—type 2 diabetes mellitus	2.35e-05	0.000258	CcSEcCtD
Nifedipine—Dermatitis—Gliclazide—type 2 diabetes mellitus	2.35e-05	0.000258	CcSEcCtD
Nifedipine—Diarrhoea—Valsartan—type 2 diabetes mellitus	2.35e-05	0.000258	CcSEcCtD
Nifedipine—Urticaria—Irbesartan—type 2 diabetes mellitus	2.34e-05	0.000257	CcSEcCtD
Nifedipine—Shock—Ramipril—type 2 diabetes mellitus	2.34e-05	0.000257	CcSEcCtD
Nifedipine—Headache—Gliclazide—type 2 diabetes mellitus	2.34e-05	0.000257	CcSEcCtD
Nifedipine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000256	CcSEcCtD
Nifedipine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	2.33e-05	0.000256	CcSEcCtD
Nifedipine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	2.33e-05	0.000256	CcSEcCtD
Nifedipine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000256	CcSEcCtD
Nifedipine—Tachycardia—Ramipril—type 2 diabetes mellitus	2.32e-05	0.000255	CcSEcCtD
Nifedipine—Diarrhoea—Orlistat—type 2 diabetes mellitus	2.32e-05	0.000255	CcSEcCtD
Nifedipine—Skin disorder—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000254	CcSEcCtD
Nifedipine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	2.3e-05	0.000252	CcSEcCtD
Nifedipine—Feeling abnormal—Losartan—type 2 diabetes mellitus	2.29e-05	0.000251	CcSEcCtD
Nifedipine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	2.27e-05	0.000249	CcSEcCtD
Nifedipine—Dizziness—Valsartan—type 2 diabetes mellitus	2.27e-05	0.000249	CcSEcCtD
Nifedipine—Anorexia—Ramipril—type 2 diabetes mellitus	2.27e-05	0.000249	CcSEcCtD
Nifedipine—Dizziness—Orlistat—type 2 diabetes mellitus	2.24e-05	0.000246	CcSEcCtD
Nifedipine—Asthenia—Metformin—type 2 diabetes mellitus	2.24e-05	0.000246	CcSEcCtD
Nifedipine—Hypotension—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000244	CcSEcCtD
Nifedipine—Nausea—Gliclazide—type 2 diabetes mellitus	2.22e-05	0.000243	CcSEcCtD
Nifedipine—Pruritus—Metformin—type 2 diabetes mellitus	2.21e-05	0.000243	CcSEcCtD
Nifedipine—Urticaria—Losartan—type 2 diabetes mellitus	2.2e-05	0.000242	CcSEcCtD
Nifedipine—Body temperature increased—Losartan—type 2 diabetes mellitus	2.19e-05	0.000241	CcSEcCtD
Nifedipine—Abdominal pain—Losartan—type 2 diabetes mellitus	2.19e-05	0.000241	CcSEcCtD
Nifedipine—Vomiting—Valsartan—type 2 diabetes mellitus	2.18e-05	0.000239	CcSEcCtD
Nifedipine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	2.17e-05	0.000238	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	2.17e-05	0.000238	CcSEcCtD
Nifedipine—Rash—Valsartan—type 2 diabetes mellitus	2.16e-05	0.000237	CcSEcCtD
Nifedipine—Dermatitis—Valsartan—type 2 diabetes mellitus	2.16e-05	0.000237	CcSEcCtD
Nifedipine—Vomiting—Orlistat—type 2 diabetes mellitus	2.15e-05	0.000237	CcSEcCtD
Nifedipine—Insomnia—Ramipril—type 2 diabetes mellitus	2.15e-05	0.000236	CcSEcCtD
Nifedipine—Headache—Valsartan—type 2 diabetes mellitus	2.15e-05	0.000236	CcSEcCtD
Nifedipine—Diarrhoea—Metformin—type 2 diabetes mellitus	2.14e-05	0.000235	CcSEcCtD
Nifedipine—Rash—Orlistat—type 2 diabetes mellitus	2.14e-05	0.000235	CcSEcCtD
Nifedipine—Paraesthesia—Ramipril—type 2 diabetes mellitus	2.14e-05	0.000234	CcSEcCtD
Nifedipine—Dermatitis—Orlistat—type 2 diabetes mellitus	2.13e-05	0.000234	CcSEcCtD
Nifedipine—Headache—Orlistat—type 2 diabetes mellitus	2.12e-05	0.000233	CcSEcCtD
Nifedipine—Dyspnoea—Ramipril—type 2 diabetes mellitus	2.12e-05	0.000233	CcSEcCtD
Nifedipine—Asthenia—Irbesartan—type 2 diabetes mellitus	2.11e-05	0.000232	CcSEcCtD
Nifedipine—Somnolence—Ramipril—type 2 diabetes mellitus	2.11e-05	0.000232	CcSEcCtD
Nifedipine—Dyspepsia—Ramipril—type 2 diabetes mellitus	2.09e-05	0.00023	CcSEcCtD
Nifedipine—Pruritus—Irbesartan—type 2 diabetes mellitus	2.09e-05	0.000229	CcSEcCtD
Nifedipine—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.07e-05	0.000227	CcSEcCtD
Nifedipine—Dizziness—Metformin—type 2 diabetes mellitus	2.07e-05	0.000227	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.05e-05	0.000225	CcSEcCtD
Nifedipine—Fatigue—Ramipril—type 2 diabetes mellitus	2.05e-05	0.000225	CcSEcCtD
Nifedipine—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.04e-05	0.000224	CcSEcCtD
Nifedipine—Nausea—Valsartan—type 2 diabetes mellitus	2.04e-05	0.000224	CcSEcCtD
Nifedipine—Constipation—Ramipril—type 2 diabetes mellitus	2.03e-05	0.000223	CcSEcCtD
Nifedipine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.02e-05	0.000221	CcSEcCtD
Nifedipine—Nausea—Orlistat—type 2 diabetes mellitus	2.01e-05	0.000221	CcSEcCtD
Nifedipine—Asthenia—Losartan—type 2 diabetes mellitus	1.99e-05	0.000218	CcSEcCtD
Nifedipine—Vomiting—Metformin—type 2 diabetes mellitus	1.99e-05	0.000218	CcSEcCtD
Nifedipine—Rash—Metformin—type 2 diabetes mellitus	1.97e-05	0.000216	CcSEcCtD
Nifedipine—Dermatitis—Metformin—type 2 diabetes mellitus	1.97e-05	0.000216	CcSEcCtD
Nifedipine—Pruritus—Losartan—type 2 diabetes mellitus	1.96e-05	0.000215	CcSEcCtD
Nifedipine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.96e-05	0.000215	CcSEcCtD
Nifedipine—Headache—Metformin—type 2 diabetes mellitus	1.96e-05	0.000215	CcSEcCtD
Nifedipine—Dizziness—Irbesartan—type 2 diabetes mellitus	1.95e-05	0.000214	CcSEcCtD
Nifedipine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.94e-05	0.000213	CcSEcCtD
Nifedipine—Diarrhoea—Losartan—type 2 diabetes mellitus	1.9e-05	0.000208	CcSEcCtD
Nifedipine—Urticaria—Ramipril—type 2 diabetes mellitus	1.89e-05	0.000207	CcSEcCtD
Nifedipine—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.88e-05	0.000206	CcSEcCtD
Nifedipine—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.88e-05	0.000206	CcSEcCtD
Nifedipine—Vomiting—Irbesartan—type 2 diabetes mellitus	1.87e-05	0.000206	CcSEcCtD
Nifedipine—Rash—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000204	CcSEcCtD
Nifedipine—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.86e-05	0.000204	CcSEcCtD
Nifedipine—Nausea—Metformin—type 2 diabetes mellitus	1.86e-05	0.000204	CcSEcCtD
Nifedipine—Headache—Irbesartan—type 2 diabetes mellitus	1.85e-05	0.000203	CcSEcCtD
Nifedipine—Dizziness—Losartan—type 2 diabetes mellitus	1.83e-05	0.000201	CcSEcCtD
Nifedipine—Vomiting—Losartan—type 2 diabetes mellitus	1.76e-05	0.000194	CcSEcCtD
Nifedipine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.75e-05	0.000192	CcSEcCtD
Nifedipine—Nausea—Irbesartan—type 2 diabetes mellitus	1.75e-05	0.000192	CcSEcCtD
Nifedipine—Rash—Losartan—type 2 diabetes mellitus	1.75e-05	0.000192	CcSEcCtD
Nifedipine—Dermatitis—Losartan—type 2 diabetes mellitus	1.75e-05	0.000192	CcSEcCtD
Nifedipine—Headache—Losartan—type 2 diabetes mellitus	1.74e-05	0.000191	CcSEcCtD
Nifedipine—Asthenia—Ramipril—type 2 diabetes mellitus	1.71e-05	0.000187	CcSEcCtD
Nifedipine—Pruritus—Ramipril—type 2 diabetes mellitus	1.68e-05	0.000185	CcSEcCtD
Nifedipine—Nausea—Losartan—type 2 diabetes mellitus	1.65e-05	0.000181	CcSEcCtD
Nifedipine—Diarrhoea—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000179	CcSEcCtD
Nifedipine—Dizziness—Ramipril—type 2 diabetes mellitus	1.57e-05	0.000173	CcSEcCtD
Nifedipine—Vomiting—Ramipril—type 2 diabetes mellitus	1.51e-05	0.000166	CcSEcCtD
Nifedipine—Rash—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000165	CcSEcCtD
Nifedipine—Dermatitis—Ramipril—type 2 diabetes mellitus	1.5e-05	0.000164	CcSEcCtD
Nifedipine—Headache—Ramipril—type 2 diabetes mellitus	1.49e-05	0.000164	CcSEcCtD
Nifedipine—Nausea—Ramipril—type 2 diabetes mellitus	1.41e-05	0.000155	CcSEcCtD
Nifedipine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	7.64e-07	1.27e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	7.63e-07	1.27e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—IL6—type 2 diabetes mellitus	7.62e-07	1.26e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—IL6—type 2 diabetes mellitus	7.62e-07	1.26e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.6e-07	1.26e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.6e-07	1.26e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.6e-07	1.26e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	7.59e-07	1.26e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	7.57e-07	1.26e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.54e-07	1.25e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	7.54e-07	1.25e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	7.53e-07	1.25e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTGS2—type 2 diabetes mellitus	7.52e-07	1.25e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTGS2—type 2 diabetes mellitus	7.52e-07	1.25e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	7.5e-07	1.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.5e-07	1.24e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	7.49e-07	1.24e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	7.48e-07	1.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—ALB—type 2 diabetes mellitus	7.45e-07	1.24e-05	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—AKT1—type 2 diabetes mellitus	7.43e-07	1.23e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	7.41e-07	1.23e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	7.4e-07	1.23e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	7.35e-07	1.22e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	7.32e-07	1.21e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	7.32e-07	1.21e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—NFKB1—type 2 diabetes mellitus	7.31e-07	1.21e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	7.29e-07	1.21e-05	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—AKT1—type 2 diabetes mellitus	7.27e-07	1.21e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.25e-07	1.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.25e-07	1.2e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	7.23e-07	1.2e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	7.23e-07	1.2e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	7.21e-07	1.2e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	7.2e-07	1.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—ALB—type 2 diabetes mellitus	7.2e-07	1.2e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—ALB—type 2 diabetes mellitus	7.2e-07	1.2e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	7.19e-07	1.19e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.17e-07	1.19e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	7.17e-07	1.19e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	7.16e-07	1.19e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	7.15e-07	1.19e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	7.15e-07	1.19e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3R1—type 2 diabetes mellitus	7.12e-07	1.18e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	7.12e-07	1.18e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—NOS3—type 2 diabetes mellitus	7.12e-07	1.18e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	7.12e-07	1.18e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	7.09e-07	1.18e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.09e-07	1.18e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NFKB1—type 2 diabetes mellitus	7.07e-07	1.17e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NFKB1—type 2 diabetes mellitus	7.07e-07	1.17e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	7.07e-07	1.17e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	7.07e-07	1.17e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	7.04e-07	1.17e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	7.04e-07	1.17e-05	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—AKT1—type 2 diabetes mellitus	7.03e-07	1.17e-05	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—AKT1—type 2 diabetes mellitus	7.03e-07	1.17e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	6.99e-07	1.16e-05	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—AKT1—type 2 diabetes mellitus	6.98e-07	1.16e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	6.93e-07	1.15e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—NOS3—type 2 diabetes mellitus	6.89e-07	1.14e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.89e-07	1.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—NOS3—type 2 diabetes mellitus	6.89e-07	1.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.89e-07	1.14e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.87e-07	1.14e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	6.86e-07	1.14e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.86e-07	1.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.86e-07	1.14e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—SRC—type 2 diabetes mellitus	6.81e-07	1.13e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	6.81e-07	1.13e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	6.79e-07	1.13e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	6.79e-07	1.13e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.76e-07	1.12e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	6.76e-07	1.12e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.75e-07	1.12e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	6.75e-07	1.12e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	6.75e-07	1.12e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.75e-07	1.12e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.75e-07	1.12e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.73e-07	1.12e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	6.72e-07	1.11e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	6.71e-07	1.11e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	6.69e-07	1.11e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	6.69e-07	1.11e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.68e-07	1.11e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—AKT1—type 2 diabetes mellitus	6.66e-07	1.1e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.65e-07	1.1e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—SRC—type 2 diabetes mellitus	6.59e-07	1.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—SRC—type 2 diabetes mellitus	6.59e-07	1.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	6.57e-07	1.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	6.57e-07	1.09e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.57e-07	1.09e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.56e-07	1.09e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	6.56e-07	1.09e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	6.54e-07	1.09e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.54e-07	1.08e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	6.52e-07	1.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	6.51e-07	1.08e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	6.48e-07	1.07e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.46e-07	1.07e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.46e-07	1.07e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.44e-07	1.07e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.35e-07	1.05e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.35e-07	1.05e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.35e-07	1.05e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.35e-07	1.05e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.32e-07	1.05e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.32e-07	1.05e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	6.3e-07	1.05e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	6.3e-07	1.05e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—SRC—type 2 diabetes mellitus	6.29e-07	1.04e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	6.28e-07	1.04e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.24e-07	1.04e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	6.2e-07	1.03e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	6.2e-07	1.03e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	6.18e-07	1.03e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	6.18e-07	1.03e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	6.16e-07	1.02e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—SRC—type 2 diabetes mellitus	6.09e-07	1.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—SRC—type 2 diabetes mellitus	6.09e-07	1.01e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	6.06e-07	1.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.03e-07	1e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.03e-07	1e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—type 2 diabetes mellitus	5.97e-07	9.91e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.96e-07	9.88e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.96e-07	9.88e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.91e-07	9.81e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	5.87e-07	9.74e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.86e-07	9.73e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.82e-07	9.65e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.82e-07	9.65e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.8e-07	9.62e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.79e-07	9.61e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—type 2 diabetes mellitus	5.78e-07	9.59e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—type 2 diabetes mellitus	5.78e-07	9.59e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	5.77e-07	9.58e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.76e-07	9.56e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.76e-07	9.56e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.76e-07	9.56e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.76e-07	9.56e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	5.75e-07	9.54e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.75e-07	9.54e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.71e-07	9.48e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	5.69e-07	9.43e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	5.67e-07	9.4e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	5.64e-07	9.36e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFB1—type 2 diabetes mellitus	5.62e-07	9.33e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.61e-07	9.3e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.55e-07	9.2e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—type 2 diabetes mellitus	5.51e-07	9.15e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFB1—type 2 diabetes mellitus	5.44e-07	9.03e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFB1—type 2 diabetes mellitus	5.44e-07	9.03e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.42e-07	9e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.42e-07	9e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.4e-07	8.96e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	5.4e-07	8.96e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.4e-07	8.95e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—type 2 diabetes mellitus	5.33e-07	8.85e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—type 2 diabetes mellitus	5.33e-07	8.85e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.32e-07	8.82e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.3e-07	8.79e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5.27e-07	8.75e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.18e-07	8.6e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.17e-07	8.57e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.09e-07	8.44e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.09e-07	8.44e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.06e-07	8.39e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	5.04e-07	8.37e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	5.04e-07	8.37e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	5.03e-07	8.35e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.02e-07	8.33e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	5.01e-07	8.31e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.97e-07	8.24e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.94e-07	8.19e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	4.91e-07	8.15e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.89e-07	8.12e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.89e-07	8.12e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.86e-07	8.06e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.86e-07	8.06e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.78e-07	7.93e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.77e-07	7.91e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.73e-07	7.84e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.68e-07	7.76e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.65e-07	7.72e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.63e-07	7.69e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.62e-07	7.67e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.62e-07	7.67e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.61e-07	7.65e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—type 2 diabetes mellitus	4.59e-07	7.62e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.57e-07	7.59e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.57e-07	7.59e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	4.55e-07	7.55e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.53e-07	7.52e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	4.5e-07	7.47e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.48e-07	7.44e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.48e-07	7.44e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.45e-07	7.39e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—type 2 diabetes mellitus	4.44e-07	7.37e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—type 2 diabetes mellitus	4.44e-07	7.37e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.44e-07	7.37e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.41e-07	7.31e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.39e-07	7.28e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.31e-07	7.15e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	4.31e-07	7.15e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.29e-07	7.12e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.26e-07	7.07e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.26e-07	7.07e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—type 2 diabetes mellitus	4.24e-07	7.03e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—type 2 diabetes mellitus	4.23e-07	7.03e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	4.17e-07	6.92e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.15e-07	6.89e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.15e-07	6.89e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—type 2 diabetes mellitus	4.1e-07	6.8e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—type 2 diabetes mellitus	4.1e-07	6.8e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—type 2 diabetes mellitus	4.1e-07	6.8e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—type 2 diabetes mellitus	4.1e-07	6.8e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.94e-07	6.54e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.94e-07	6.53e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—type 2 diabetes mellitus	3.91e-07	6.49e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.87e-07	6.42e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.86e-07	6.41e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.81e-07	6.32e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.81e-07	6.32e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.79e-07	6.29e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—type 2 diabetes mellitus	3.78e-07	6.27e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—type 2 diabetes mellitus	3.78e-07	6.27e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.74e-07	6.2e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.74e-07	6.2e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.48e-07	5.77e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	3.36e-07	5.58e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.33e-07	5.52e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.33e-07	5.52e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	3.3e-07	5.47e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	3.29e-07	5.46e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	3.27e-07	5.43e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-07	5.25e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-07	5.25e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	3.11e-07	5.15e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.04e-07	5.05e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.97e-07	4.92e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.87e-07	4.76e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.87e-07	4.76e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.85e-07	4.73e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.74e-07	4.54e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.65e-07	4.39e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.65e-07	4.39e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.48e-07	4.12e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.34e-07	3.88e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.32e-07	3.85e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.98e-07	3.29e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.53e-07	2.54e-06	CbGpPWpGaD
